Status:
COMPLETED
Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Laryngeal Neoplasms
Eligibility:
All Genders
18-90 years
Brief Summary
The main objective of this study is to determine the rate of healthy surgical margins after tumor resection in transoral robot-assisted surgery for glottic and/or supraglottic early stage (T1-T2) lary...
Eligibility Criteria
Inclusion
- The subject has signed consent
- The subject must be a member or beneficiary of a health insurance plan
- The patient is available for 12 months of follow-up
- The subject has a cancer of the larynx:
- classified T1 or T2 in the TNM
- glottic localization and / or supraglottic regardless of node status
- with or without a history of head and neck cancer
- The subject does not have distant metastasis (M0)
- A decision for endoscopic robot-assisted surgery is retained in multidisciplinary meeting
Exclusion
- \-
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2014
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT01257633
Start Date
April 1 2011
End Date
September 30 2014
Last Update
November 17 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, Gard, France, 30029
2
CHU de Montpellier - Hôpital Gui de Chauliac
Montpellier, France, 34295
3
CHRU de Toulouse - Hôpital de Rangueil
Toulouse, France, 31059